Aethlon Medical Inc (AEMD) — 10-Q Filings

10-Q Filings (6)

• Aethlon Narrows Losses, Boosts Cash Amid Hemopurifier Trial Progress — Nov 12, 2025 Risk: high
  Aethlon Medical, Inc. (AEMD) reported a net loss of $3,248,958 for the six months ended September 30, 2025, a significant improvement from the $5,378,414 net lo
• Aethlon Narrows Q1 Loss by 31% Amid Hemopurifier Trial Progress — Aug 13, 2025 Risk: high
  Aethlon Medical, Inc. (AEMD) reported a net loss of $1,761,858 for the three months ended June 30, 2025, a 31.3% improvement from the $2,571,440 net loss in the
• Aethlon Medical Files Q3 2025 10-Q — Feb 12, 2025 Risk: medium
  Aethlon Medical, Inc. filed its 10-Q for the period ending December 31, 2024. The company, incorporated in Nevada and headquartered in San Diego, CA, operates i
• Aethlon Medical Reports Narrowed Net Loss in Q2 2024 — Nov 13, 2024 Risk: medium
  Aethlon Medical, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported a net loss of $3.5 million for the six months ended Septembe
• Aethlon Medical Files Q1 FY2025 10-Q — Aug 14, 2024 Risk: medium
  Aethlon Medical, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported its financial results for the first quarter of fiscal year 2025.
• Aethlon Medical Inc. Files 10-Q for Period Ending December 31, 2023 — Feb 14, 2024 Risk: low
  AETHLON MEDICAL INC (AEMD) filed a Quarterly Report (10-Q) with the SEC on February 14, 2024. Aethlon Medical Inc. filed a 10-Q report for the period ending Dec

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX